Citigroup Begins Coverage on agilon health (NYSE:AGL)

Citigroup initiated coverage on shares of agilon health (NYSE:AGL) in a research note published on Monday morning, MarketBeat Ratings reports. The brokerage issued a neutral rating and a $6.00 price target on the stock.

AGL has been the topic of several other reports. Benchmark cut their target price on shares of agilon health from $13.00 to $9.00 and set a buy rating on the stock in a research note on Thursday, February 29th. Leerink Partnrs lowered shares of agilon health from an outperform rating to a market perform rating in a research note on Monday, January 8th. JPMorgan Chase & Co. lowered shares of agilon health from an overweight rating to a neutral rating and cut their target price for the stock from $17.00 to $9.00 in a research note on Friday, January 5th. SVB Leerink downgraded shares of agilon health from an outperform rating to a market perform rating in a report on Monday, January 8th. Finally, Royal Bank of Canada lowered their price objective on shares of agilon health from $11.00 to $8.00 and set an outperform rating on the stock in a report on Wednesday, February 28th. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, agilon health presently has an average rating of Hold and an average target price of $9.46.

agilon health Trading Down 0.3 %

NYSE:AGL opened at $5.33 on Monday. The firm’s fifty day moving average is $5.64 and its 200-day moving average is $9.63. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.51 and a current ratio of 1.51. agilon health has a 52 week low of $4.41 and a 52 week high of $26.75. The firm has a market cap of $2.19 billion, a P/E ratio of -8.19 and a beta of 0.49.

agilon health (NYSE:AGL) last issued its earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.13). The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.02 billion. agilon health had a negative return on equity of 21.74% and a negative net margin of 5.76%. The firm’s revenue was up 71.8% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.14) earnings per share. Equities analysts expect that agilon health will post -0.35 earnings per share for the current year.

Institutional Trading of agilon health

Several institutional investors and hedge funds have recently made changes to their positions in AGL. CWM LLC raised its holdings in shares of agilon health by 83.7% in the third quarter. CWM LLC now owns 1,585 shares of the company’s stock valued at $28,000 after purchasing an additional 722 shares during the last quarter. Ronald Blue Trust Inc. purchased a new stake in agilon health during the third quarter worth about $38,000. SG Americas Securities LLC raised its position in agilon health by 98.3% in the third quarter. SG Americas Securities LLC now owns 12,886 shares of the company’s stock worth $229,000 after acquiring an additional 6,389 shares during the period. Handelsbanken Fonder AB raised its position in agilon health by 28.8% in the third quarter. Handelsbanken Fonder AB now owns 42,000 shares of the company’s stock worth $746,000 after acquiring an additional 9,400 shares during the period. Finally, Harbor Capital Advisors Inc. raised its position in agilon health by 46.4% in the third quarter. Harbor Capital Advisors Inc. now owns 7,717 shares of the company’s stock worth $137,000 after acquiring an additional 2,445 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.